Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market Forecast 2026–2030 Highlighting Industry Drivers And Growth Trends

Global Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market Expected To Change From 2026 To 2030?

The market size for the point of care (POC) tuberculosis (TB) ultra-sensitive nucleic acid amplification test (NAAT) has experienced swift expansion in recent years. This market is projected to expand from $0.88 billion in 2025 to reach $1 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 13.3%. Historically, this growth can be ascribed to factors such as rising tuberculosis prevalence, the adoption of conventional molecular diagnostics, increasing government health initiatives, the expansion of hospital networks, and growing awareness of the benefits of early diagnosis.

The market size for the point of care (POC) tuberculosis (TB) ultra-sensitive nucleic acid amplification test (NAAT) is poised for substantial growth in the upcoming years. It is anticipated to expand to $1.66 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.5%. This projected growth can be attributed to the rising demand for ultra-sensitive point-of-care testing, the integration of AI with diagnostic assays, the expansion of decentralized healthcare, investments in rapid nucleic acid amplification technologies, and increased funding for tuberculosis control programs. Significant trends expected during the forecast period encompass rapid point-of-care testing, ultra-sensitive nucleic acid amplification, automated diagnostic platforms, compact and portable test devices, and their integration with electronic health records.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample_request?id=61723794&type=smp&name=Point%20Of%20Care%20%28POC%29%20Tuberculosis%20%28TB%29%20Ultra-Sensitive%20Nucleic%20Acid%20Amplification%20Test%20%28NAAT%29%20Market%20Report%202026

Which Key Drivers Are Affecting The Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market Development?

The increasing occurrence of infectious diseases is projected to stimulate the growth of the point of care (POC) tuberculosis (TB) ultra-sensitive nucleic acid amplification test (NAAT) market in the future. Infectious diseases are ailments resulting from pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which can spread among individuals through direct or indirect means. The escalating incidence of infectious diseases is fueled by the growing density of the global population, which intensifies transmission risks and the spread of illnesses. Point-of-care tuberculosis ultra-sensitive nucleic acid amplification testing supports the rising prevalence of infectious diseases by enabling swift, highly sensitive, and decentralized detection of infectious pathogens, thereby strengthening early diagnosis and disease control initiatives. As an illustration, in March 2025, according to the UK Health Security Agency, a UK-based government health authority, tuberculosis cases in England saw a 13% increase in 2024, reaching 5,480 cases compared to 4,850 cases in 2023. Thus, the increasing prevalence of infectious diseases is driving the expansion of the point of care (POC) tuberculosis (TB) ultra-sensitive nucleic acid amplification test (NAAT) market.

What Are The Main Segments Within The Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market Segment Structure?

The point of care (POC) tuberculosis (TB) ultra-sensitive nucleic acid amplification test (NAAT) market covered in this report is segmented –

1) By Technology: Polymerase Chain Reaction Based Nucleic Acid Amplification Testing, Isothermal Amplification, Other Technologies

2) By Product Type: Instruments, Reagents And Consumables, Software

3) By Sample Type: Sputum, Blood, Urine, Other Sample Types

4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users

Subsegments:

1) By Polymerase Chain Reaction Based Nucleic Acid Amplification Testing: Real Time Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Multiplex Polymerase Chain Reaction, Nested Polymerase Chain Reaction

2) By Isothermal Amplification: Loop Mediated Isothermal Amplification, Recombinase Polymerase Amplification, Nucleic Acid Sequence Based Amplification, Strand Displacement Amplification

3) By Other Technologies: Transcription Mediated Amplification, Helicase Dependent Amplification, Rolling Circle Amplification, Branched DNA Amplification

What Trends Are Transforming The Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market?

Leading companies operating within the point of care (POC) tuberculosis (TB) ultra-sensitive nucleic acid amplification test (NAAT) market are focusing on achieving regulatory validation and participating in international prequalification programs. This strategic emphasis aims to bolster quality assurance, accelerate global adoption rates, and enhance access to highly sensitive diagnostic solutions. Prequalification itself is a regulatory assessment procedure that evaluates in vitro diagnostic products to ensure their compliance with international benchmarks for quality, safety, and performance, thereby making them eligible for procurement by global health organizations and deployment in settings with limited resources. For example, in December 2024, the World Health Organization, a Switzerland-based intergovernmental organization, announced the initial prequalification of an Xpert MTB/RIF, an ultra-tuberculosis diagnostic test, under its established regulatory assessment framework. This significant achievement supports the broader dissemination of reliable and rapid TB detection tools, particularly in low- and middle-income countries. Leveraging advanced nucleic acid amplification technology, automated cartridge-based systems, and swift result turnaround capabilities, this solution facilitates decentralized testing, improves the early identification of cases, and strengthens the detection of drug resistance. It is specifically engineered for deployment in primary healthcare facilities and remote areas with constrained laboratory infrastructure, consequently enhancing surveillance capacity, minimizing diagnostic delays, and supporting global tuberculosis control and antimicrobial resistance management initiatives.

Who Are The Companies Participating In The Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market?

Major companies operating in the point of care (POC) tuberculosis (TB) ultra-sensitive nucleic acid amplification test (NAAT) market are (POC) tuberculosis (TB) ultra-sensitive nucleic acid amplification test (NAAT) market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, QIAGEN N.V., SD BIOSENSOR Inc., Eiken Chemical Co. Ltd, Oxford Nanopore Technologies Ltd, Molbio Diagnostics Limited, Sansure Biotech Inc., CapitalBio Corporation, QuantuMDx Group Limited, Tata Medical Diagnostics Limited, Ustar Biotechnologies, Mylab Discovery Solutions Private Limited, GenoScreen SAS, Co-Diagnostics Inc., Longhorn Vaccines Diagnostics LLC, Akonni Biosystems Inc., Zeesan Biotech Co. Ltd, Redcliffe labs.

Get The Full Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market Report:

https://www.thebusinessresearchcompany.com/report/point-of-care-poc-tuberculosis-tb-ultra-sensitive-nucleic-acid-amplification-test-naat-market-report

Which Region Is The Largest In The Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market?

North America was the largest region in the point of care (POC) tuberculosis (TB) ultra-sensitive nucleic acid amplification test (NAAT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care (POC) tuberculosis (TB) ultra-sensitive nucleic acid amplification test (NAAT) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/Customise?id=61723794&name=Point%20Of%20Care%20%28POC%29%20Tuberculosis%20%28TB%29%20Ultra-Sensitive%20Nucleic%20Acid%20Amplification%20Test%20%28NAAT%29%20Market%20Report%202026&type=smp

Browse Through More Reports Similar to the Global Point Of Care (POC) Tuberculosis (TB) Ultra-Sensitive Nucleic Acid Amplification Test (NAAT) Market 2026, By The Business Research Company

connected health personal medical devices market report 2026

https://www.thebusinessresearchcompany.com/report/connected-health-personal-medical-devices-global-market-report

contract sterilization market report 2026

https://www.thebusinessresearchcompany.com/report/contract-sterilization-global-market-report

orthotic insole 3-d printer market report 2026

https://www.thebusinessresearchcompany.com/report/orthotic-insole-3-d-printer-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model